It has been shown that in gliomas OCT4 expression is maintained by the transcription factors FOXO1 and FOXO3 and suppressed by PI3K/Akt/mTOR, and its level is significantly enhanced when PI3K is inhibited simultaneously with mTOR or MEK [37]. The gene discussed is MTOR; the disease is central nervous system cancer.